meglumine has been researched along with Adenoma Sebaceum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessou, P; Chateil, JF; Crombé, A; Gaillard, AL; Havez, M; Jecko, V; Pédespan, JM; Van Gils, J | 1 |
| Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA | 1 |
1 review(s) available for meglumine and Adenoma Sebaceum
| Article | Year |
|---|---|
MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Topics: Adolescent; Adult; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tuberous Sclerosis | 1992 |
1 other study(ies) available for meglumine and Adenoma Sebaceum
| Article | Year |
|---|---|
Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
Topics: Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tuberous Sclerosis | 2020 |